Chemical Structure (Lovaza 01)
Lovaza Capsule
Product Images NDC 80725-420
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lovaza (NDC 80725-420). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Waylis Therapeutics Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Chemical Structure (Lovaza 02)
Principal Display Panel (1 gram Bottle Label)
This is a description for Lovaza® capsules, a prescription medication containing omega-3-acid ethyl esters. Each capsule provides 1 gram of omega-3-acid ethyl ester liquid concentrate, with at least 900 mg of omega-3-acid ethyl esters. The capsule includes 465 mg of Eicosapentenoic acid (EPA) ethyl ester and 375 mg of Docosahexaenoic acid (DHA) ethyl ester. The recommended dosage and prescribing information should be followed. Store the capsules at 20° to 25°C (68 to 77°F) with excursions allowed between 15° to 30 °C (59° to 86°F). Protect from light and do not freeze. The medication is manufactured by Waylis Therapeutics LLG in Rahway, NJ.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
